Semaglutide is approved in different forms for specific medical uses, depending on the brand name and labeling: Ozempic (semaglutide injection) Type 2 diabetes (T2D): to improve blood sugar control in adults Cardiovascular (CV) risk reduction: to reduce the risk of major cardiovascular events (such as heart attack or stroke) in certain adults with type 2 diabetes and known heart disease Wegovy (semaglutide injection) Chronic weight management: for eligible patients based on BMI criteria and clinical guidelines Adolescents ages 12+: approved for chronic weight management in adolescents who meet the label criteria Quick warning: Dont assume that what you see on social media reflects an FDA-approved use
This morning, I found out that there are actually B12 shots and Im always willing to use my body as a guinea pig
Common panels include A1C or fasting glucose, kidney and liver function, fasting lipids, and thyroid markers
Availability and Access: Semaglutide is more widely available, but Tirzepatide is quickly gaining traction due to its recent FDA approval for use in diabetes, with ongoing studies likely to lead to its approval for weight loss
ResultsStudy selection and population Our initial search identified 1978 potential studies from three databases (i.e., PubMed, Cochrane Central, ClinicalTrials.gov, and Web of Science)
